Axon announced that Dr. Richard Carmona, the 17th US Surgeon General, will be retiring from Axon's board after 15 years of serving as a director. He will stay on through the spring 2022 shareholder meeting to oversee Axon's implementation of several important governance changes.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
317.3 USD | -0.67% |
|
+7.97% | +22.58% |
01:50pm | Jefferies Initiates Axon Enterprise at Buy With $385 Price Target | MT |
01:49pm | BofA Securities Initiates Axon Enterprise at Buy With $380 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.58% | 24.11B | |
+24.60% | 138B | |
+12.97% | 79.87B | |
-7.00% | 64.4B | |
+49.22% | 50.25B | |
+14.00% | 50.04B | |
+13.43% | 45.6B | |
+90.06% | 42.65B | |
+77.27% | 28.55B | |
+68.54% | 24.26B |
- Stock Market
- Equities
- AXON Stock
- News Axon Enterprise, Inc.
- Axon Announces Retirement of Richard Carmona as Director